FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS
Clinical trials for FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS trials appear
Sign up with your email to follow new studies for FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could help teens with inherited high cholesterol
Disease control CompletedThis study tested a drug called inclisiran in teenagers aged 12 to 18 who have a genetic condition that causes very high cholesterol. The goal was to see if the drug safely lowers bad cholesterol (LDL-C) compared to a placebo. Participants received either inclisiran or placebo fo…
Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
Heart attack patients screened for hidden genetic cholesterol disorder
Diagnosis CompletedThis study tested whether offering genetic testing for familial hypercholesterolemia (a genetic condition causing very high cholesterol) to people hospitalized for a heart attack could help doctors diagnose the condition more often. Researchers enrolled 140 patients under age 60 …
Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS
Phase: NA • Sponsor: University of British Columbia • Aim: Diagnosis
Last updated May 26, 2026 09:34 UTC